MedTrace Logo

Assessment of Stent Strut Coverage and Endothelial Function After Drug-Eluting Stents

NCT01073111 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-08-03

No results posted yet for this study

Summary

The purpose of this study is to compare coronary endothelium function in patients with a zotarolimus-eluting versus a sirolimus-eluting or a everolimus-eluting stents with optical coherence tomography, vasoconstriction in response to acetylcholine, and coronary biomarker level.

Conditions

Interventions

DEVICE

zotarolimus-eluting stent (ENDEAVOR®)

zotarolimus-eluting stent

DEVICE

sirolimus-eluting stents (CYPHER SELECT® PLUS)

sirolimus-eluting stents

DEVICE

everolimus-eluting stents (PROMUS®)

everolimus-eluting stents

Sponsors & Collaborators

  • Hyogo Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2011-10-31
Completion
2017-02-28

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01073111 on ClinicalTrials.gov